Equine Sports Council

Controlled Medications Library

ESC Medication Library · Revision 2

← Medication library · Compare sanctioning bodies

Medication Facts

Performance enhancing
N/A
Total hours to clear
N/A
Frequently used
Not recorded
ESC ID
NERVE-0620
Trade names
Not recorded
Drug type
N/A
Plasma half-life · hours
N/A
Equine dosing
N/A
Cmax · peak plasma concentration
N/A
Tmax · time to peak plasma concentration
N/A
ESC concentration guidance
N/A
Primary withdrawal · hours
N/A
Washout withdrawal · hours
Not recorded
ESC control type
N/A
Medication report required
N/A

Uses & side effects

Nerve

Product-specific side effects await source review.

Drug interactions

In equine medicine and regulatory oversight, nerve medications are strictly evaluated based on whether they treat neurological diseases (such as EPM), manage chronic nerve pain (such as laminitis or arthritis), or act as local anesthetics to block pain during performance.Under USEF, FEI, and HISA regulations, nerve-blocking agents and behavioral neuromodulators carry some of the strictest penalties in the sport.1. Local Anesthetics (Nerve Blocks)These medications physically block nerve conduction to eliminate pain in a specific region of the body. They are routinely used for lameness diagnostics but are strictly prohibited in competition because masking a structural injury can lead to catastrophic breakdown.Mepivacaine Hydrochloride (Carbocaine®): The gold standard for diagnostic equine nerve blocks (e.g., palmar digital nerve blocks) due to its rapid onset and minimal tissue irritation.Lidocaine Hydrochloride: A shorter-acting local anesthetic used for minor surgical procedures, skin suturing, or line blocks.Bupivacaine Hydrochloride: A long-acting local anesthetic utilized for extended post-operative pain relief or deep axial blocks (such as sacroiliac or dental nerve blocks).Regulatory Status: Banned on competition days. The detection of any local anesthetic in a competition sample constitutes a severe drug violation.2. Chronic Nerve Pain & Neuropathic MedicationsThese medications alter how the central nervous system processes chronic, maladaptive pain signals, such as those from chronic laminitis, navicular disease, or neck arthritis.Gabapentin: A neuropathic pain modulator increasingly used off-label in equine medicine. It targets the voltage-gated calcium channels in the spinal cord to alleviate chronic, burning nerve pain that traditional NSAIDs cannot touch.Amiantone / Ammonium Sulfate (Sarapin®): An injectable botanical extract used by veterinarians for regional nerve blocks or intramuscular "pitching" to dull chronic nerve pain in the back, hocks, or stifle region without causing motor impairment.3. Anti-Protozoal Neurological MedicationsThese medications target the protozoa responsible for Equine Protozoal Myeloencephalitis (EPM), a devastating neurological disease that attacks the horse's brain and spinal cord, causing muscle wasting and ataxia.Ponazuril (Marquis®): An FDA-approved oral paste that crosses the blood-brain barrier to kill the protozoa (Sarcocystis neurona).Diclazuril (Protazil®): An FDA-approved top-dress pellet formulation utilized for convenient, daily EPM treatment.Toltrazuril / Pyrimethamine / Sulfadiazine: Alternative or compounded combinations utilized in aggressive or refractory neurological cases.Regulatory Status: Generally permitted for therapeutic use during USEF competitions, provided the horse is deemed neurologically safe to compete by a veterinarian.4. Forbidden Long-Acting NeuromodulatorsThese medications are human psychotropic drugs or antipsychotics that are illicitly used in performance horses to sedate nerves and alter behavior over weeks or months.Fluphenazine Decanoate & Reserpine: Long-acting antipsychotics that permanently alter dopamine and norepinephrine pathways to keep a horse unnaturally quiet.

Contraindications

Sanctioning-body comparison

Plasma only. Compare published competition guidance for this medication. ESC guidance remains in Medication Facts above. A dosing guideline, withdrawal recommendation and laboratory detection threshold are different measures.

Sources reviewed September 23, 2026. “Not verified” means a gap in this comparison, not zero tolerance or permission. Doses describe the cited rules; your veterinarian must determine treatment and withdrawal.

Published guidance by organization
OrganizationPublished dose & routePlasma concentrationWithdrawal / timingControl / penalty class
AQHA Show HorsesShow rules · 2026 handbook
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
APHA Paint Show HorsesShow rules · 2026 Rule Book
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
ARCI Model RulesRacing model · Rules 15 / UCG 20.0 / CTMS 4.2.1
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.
USEFNational Therapeutic Substance Provisions · 2026 + July amendment
Conditions & sources

An unverified entry is not permission to use this medication. Consult the linked current rules.

Reviewed 2026-09-23

Not verified for this medication.Not verified for this medication.Not verified for this medication.Medication-specific control not yet verified.